Regulation of Ca2+ for Cancer Cell Apoptosis through Photothermal Conjugated Nanoparticles

ACS Appl Bio Mater. 2022 Jun 20;5(6):2834-2842. doi: 10.1021/acsabm.2c00236. Epub 2022 Jun 1.

Abstract

Ca2+ overload is caused by the abnormal accumulation of Ca2+, which is a potential therapeutic strategy for inhibiting tumor growth. However, due to the limited intracellular Ca2+ concentration, its anticancer effect is non-significant. Herein, near-infrared (NIR)-responsive nanoparticles NPs-PCa (DPPC-DSPE-PEG2000-NH2@PDPP@CaO2@DOX) were designed and prepared to achieve photothermal trigger of Ca2+ release, thereby increasing intracellular Ca2+ content. Furthermore, the nanoparticles convert light to heat to activate the transient receptor potential cation channel subfamily V member 1 (TRPV1) ion channels, allowing external Ca2+ to flow into the cells, further increasing the Ca2+ concentration. NPs-PCa nanoparticles overcome the limitation of insufficient concentration by increasing Ca2+ in both internal and external approaches. Meanwhile, an imbalance of intracellular Ca2+ induces mitochondrial dysfunction and ultimately results in cancer cell death. This study provides an effective strategy for inhibiting breast cancer tumor growth by regulating Ca2+ concentration.

Keywords: Ca2+; TRPV1 ion channel; antitumor; near-infrared light; photothermal conjugated polymer nanoparticles; regulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Breast Neoplasms*
  • Doxorubicin / pharmacology
  • Female
  • Humans
  • Nanoparticles* / therapeutic use

Substances

  • Doxorubicin